RE: Urgent need …20 Jan 2022 09:22
Hi Theosus,
I doubt and hope NICE are not looking at this product currently however much better is actually happening, please let me explain.
UK prescription health products, because they purchase decent quantities tend to purchase a very low prices. Also on a global perspective uk is although a decent market is actually small fry. No way would we ever agree to a poor margin deal for the uk and shoot ourselves in the foot for the rest of the world. Bit of a case for short term relief, but loose the huge multi bagger potential in the longer game which us investors are aiming at.
Yes we did the study in the uk, as research and management team are uk based, but have already moved our AXIS production to the world specialists in Amsterdam, a international low taxation and major distribution centre, along with sizable storage able to cope with international quantities.
Soft launch has started, and many small issues and problems have been sorted out, now we are looking at our priority market "with the huge tribe across the pond". Many thousands of samples have been donated to our "NPF partner", for the use for their suffering members. This product which we know works well, has actually been rushed into production ahead of schedule at the request of the NPF, they even had a say in the price point, and are giving us free advertising, while they also look at the product and see the effects on a hell of a lot more members than our study did.
WE know it works well, so can expect similar results with our USA psoriasis sufferers, who will then report back to the mainstay of sufferers in the USA. Thats where the real market will be forged not the uk. Many USA sufferers will probably purchase product directly, as not to trigger their private health care policies, which run similar to car no claims bonus's.
None of these plans could have been achieved without the product and having ample supply ready to back it up when required. Also demonstrates why a soft launch had to be done, believe Stuart and the team were very busy indeed sorting out a lot more teething issues than we know about and believe they would have resulted in unsatisfied customers had the launch been "all guns blazing". This is the last thing we want.